Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Depomed, Inc.
Depomed Reports First Quarter 2009 Financial Results
May 23rd, 2009
Depomed, Inc. (NASDAQ: DEPO) reported financial results for the first quarter ended March 31, 2009. Revenue for the three months ended March 31, 2009 was $9.9 million compared to $5.7 million for the three months ended March 31, 2008. Operating expenses for the three months ended March 31, 2009 were $19.0 million compared to $12.6 million for the three months ended March 31, 2008. The increase in operating expenses was primarily attributable to $4.5 million in promotion fee expense related to the Company’s promotion agreement for GLUMETZA with Santarus, which began promotion of GLUMETZA in October 2008, and an increase in expenses associated with the...
Source: Law & Health Weekly (2009-05-23)
|
